ERBB2 and breast cancer: In addition, when cN0 breast cancer patients with specific biological characteristics such as triple-negative or human epidermal growth factor receptor 2 (HER2)-positive disease achieved breast pCR after receiving NAC, the postoperative lymph node-positive (ypN+) rate was even lower than 2% [26,27].